R A Knudson
Overview
Explore the profile of R A Knudson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
1447
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Inoue S, Stemmer A, Inoue T, Knudson R
Biol Bull
. 2018 Jan;
181(2):336-337.
PMID: 29304638
No abstract available.
2.
Hu G, Dasari S, Asmann Y, Greipp P, Knudson R, Benson H, et al.
Leukemia
. 2017 Oct;
32(2):565-569.
PMID: 29026208
No abstract available.
3.
Goda M, Inoue S, Knudson R
Biol Bull
. 2017 Jun;
195(2):212-214.
PMID: 28570180
No abstract available.
4.
Chavan R, Bridges A, Knudson R, Ketterling R, Comfere N, Wada D, et al.
Blood Cancer J
. 2014 Oct;
4:e253.
PMID: 25325303
No abstract available.
5.
Patnaik M, Itzykson R, Lasho T, Kosmider O, Finke C, Hanson C, et al.
Leukemia
. 2014 Apr;
28(11):2206-12.
PMID: 24695057
In a cohort of 466 patients, we sought to clarify the prognostic relevance of ASXL1 and SETBP1 mutations, among others, in World Health Organization-defined chronic myelomonocytic leukemia (CMML) and its...
6.
Guglielmelli P, Lasho T, Rotunno G, Score J, Mannarelli C, Pancrazzi A, et al.
Leukemia
. 2014 Feb;
28(9):1804-10.
PMID: 24549259
We recently defined a high-molecular risk category (HMR) in primary myelofibrosis (PMF), based on the presence of at least one of the five 'prognostically detrimental' mutated genes (ASXL1, EZH2, SRSF2...
7.
Tefferi A, Lasho T, Finke C, Knudson R, Ketterling R, Hanson C, et al.
Leukemia
. 2014 Jan;
28(7):1472-7.
PMID: 24402162
Calreticulin (CALR) mutations were recently described in JAK2 and MPL unmutated primary myelofibrosis (PMF) and essential thrombocythemia. In the current study, we compared the clinical, cytogenetic and molecular features of...
8.
Vannucchi A, Lasho T, Guglielmelli P, Biamonte F, Pardanani A, Pereira A, et al.
Leukemia
. 2013 Apr;
27(9):1861-9.
PMID: 23619563
Patient outcome in primary myelofibrosis (PMF) is significantly influenced by karyotype. We studied 879 PMF patients to determine the individual and combinatorial prognostic relevance of somatic mutations. Analysis was performed...
9.
Pardanani A, Lasho T, Laborde R, Elliott M, Hanson C, Knudson R, et al.
Leukemia
. 2013 Apr;
27(9):1870-3.
PMID: 23604229
Truncation mutations of the receptor cytoplasmic domain for colony-stimulating factor 3 (CSF3R) are frequently seen in severe congenital neutropenia, whereas activating missense mutations affecting the extracellular domain (exon 14) have...
10.
Laborde R, Patnaik M, Lasho T, Finke C, Hanson C, Knudson R, et al.
Leukemia
. 2013 Apr;
27(10):2100-2.
PMID: 23558523
No abstract available.